Matter MA, Paneni F, Libby P, Frantz S, Stahli BE, Templin C, Mengozzi A, Wang YJ, Kundig TM, Raber L, Ruschitzka F, Matter CM (2024) Inflammation in acute myocardial infarction: the good, the bad and the ugly
The donation process removes approximately 600-800 mL of plasma (per FDA regulations in 21 CFR 640.65), which can temporarily affect fluid balance, blood pressure, and metabolic homeostasisfactors particularly relevant for patients managing diabetes or undergoing active weight loss
It is possible that Medicare could select semaglutide for drug price negotiation as early as 2025, based on its earliest FDA approval in late 2017, with a negotiated price available beginning in 2027
Improved sleep quality is frequently one of the earliest benefits, with patients reporting deeper, more restful REM cycles